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 Background: Trend analysis is an important tool to monitor epidemiological changes of disease over 
time to guide resource allocation. This study aimed to study incidence trends and change-points of 
smear positive, smear negative, extra-pulmonary and relapse of tuberculosis (TB) in Iran from 2001 
to 2015. 
Study design: Repeated cross-sectional study 
Methods: Nonlinear segmented regression w as used to describe TB incidence trends; annual percent 
change (APC), average annual percent changes (AAPC) and change points for each disease 
separately.   
Results: Of 154930 TB cases, 49.8% w ere smear positive, 19.7% smear negative, 27.32% extra-
pulmonary and 3.18% relapse. For all TB types, the peak of incidence w as in 2001. Tw o change point 
w ere estimated for all TB types (P<0.05). The APC of all TB types w ere -6.51 (95% CI: -7.4, -5.4) for 
f irst and 2.4 (95% CI: 0. 7, 4.1) for second segment. Although the trends w ere signif icantly decreasing 
from 2001 to 2015 for smear positive (AAPC=2.06%), smear negative (AAPC=3.57%), extra 
pulmonary (AAPC=3.2%) and relapse (AAPC=3.3%), the AAPCs of trends w ere not signif icant from 
2006 to 2015. Except for Extra pulmonary TB (APC=4-.9%, 95%CI:-10, 1.2), the APCs of the last 
segments w ere signif icant. 
Conclusions: Even though the TB incidence rates w ere decreasing, the amount of reductions seem 
inadequate, to reach the goals of TB control in Iran. Especially, the increase in the extra-pulmonary 
TB rates is a point of concern that highlights more attention is required for these cases. It is essential 
to improve economic supports tow ard TB control, illegal immigrants, data registry systems and 
physician's sensitivity in TB detection. 
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Introduction 
uberculosis (TB) causes ill-health in millions of people 
each year and it was one of the top 10 causes of death 
worldwide in 20151. According to last report WHO in 
2015, there were an estimated 10.4 million new TB cases 
worldwide (including 56% among man and 10% among 
children)1. In addition, the 6314151 new cases notified that 
14.5% and 6.5% of them were Extra-pulmonary TB (EPTB) 
and relapse cases, respectively2. Additionally, one of the five 
detected cases of TB has EPTB form3. There were also 1.8 
million death from TB cases including HIV positive (0.4 
million), and death in men was 2.48 times approximately 
higher than in women (62%/25% deaths) 1.  
As an intermediate TB burden country, 10290 new TB 
cases were reported in Iran in 2015, of which 4924 (48.61%) 
were smear positive (SP), 2863 (28.26%) EPTB, 1478 
(14.59%) smear negative (SN) and 299 (2.95%) relapse cases 4. 
The highest relative risk of SP incidence rate was related to 
provinces of Sistan-Baluchestan (relative risk=4.2) followed 
by Golestan (relative risk =3.18) and Khorasan-Razavi 
(relative risk =1.67)5,6.  
For control of TB, implementation of treatment short-
course and BCG vaccination has been started in Iran from 
1984. Subsequently, the treatment short-course was replaced 
with DOTS strategy in 19954. In spite of this, like many other 
countries, TB remains major cause of health problems in Iran7. 
The target for TB control strategy is to have <1 case per 1 
million per year until 2050 and an 80% decline in the TB 
incidence rate by 2030, compared with 20151. Study the trend 
of incidence or mortality rates over time provides important 
measures for assess the effect of controlling programs and 
health policies for government, and understanding the 
mechanisms behind observed changes to develop 
corresponding control strategies 8,9. 
T 
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Various models are used for determining the trend of 
incidence or mortality rates. Segmented regression models is 
popular models of trend analysis in incidence or mortality rate 
to estimate the changes rate and changes in time. In this model, 
the trend can be described by Annual Percent Change (APC) 
and Average Annul Percent Changes (AAPC) 10,11. 
APC and AAPC provide summery statistics that facilitate 
visual comparisons of disease incidence. Studies are used 
segmented regression models to analysis the trend of TB 
incidence rate. In this model, APC is estimated by fitting a 
simple linear model on logarithm of rates regressed on time. 
Constant rate of change for each segment is assumption of 
implementation of APC. AAPC describes and compares the 
rate of change that has not limitation of APC and will be same 
when there is no transition on trend8. There was no study to 
evaluate national TB trend base on TB types in Iran. Moreover, 
the most studies were conducted based on local information12.  
The objective of this study was to assess the efficacy of TB 
controlling programs in Iran by determining the extent changes 
of SP, SN, EPTB and relapse incidence rate per 100000 
population during 2001-2015 and to estimate point in time 
point at which the TB changed. 
Methods 
In this repeated cross-sectional study, we provided the 
incidence rates on notified smear-positive, smear-negative, 
extra-pulmonary and relapse TB cases from 21 March 2001 to 
21 March 2016, following WHO guidelines, coming from the 
reports published by the Ministry of Health of Iran, which 
hosts the national TB surveillance system. We excluded cases 
were HIV positive, because of unavailable information. The 
study area consisted of 31 provinces of Iran with total 
landmass of 1,648,195 km2 and a population of over 80 million 
inhabitants (2016 population census). The Alborz Province 
before 2010 was part of Tehran Province, so data of these 
provinces were analyzed together (merged).  
In Iran, TB controlling programs are included in healthcare 
systems since 1990, further implementation of DOTS strategy 
and "DOTS II" strategy started since 1996 and 2010, 
respectively. The TB surveillance programmer uses passive 
case finding. According to the WHO recommendation, TB 
patients are treated with an intensive phase of 2 months, 
followed by a continuation phase of 4 months regimens. 
Currently, there are 497 free TB diagnostic and treatment 
centers in Iran with at least one cultivation center in each 
province. These centers quarterly report data from verified TB 
cases to the “Administration of Tuberculosis and Leprosy 
Control” of Ministry of Health and Medical Education using 
electronic forms. In addition, annual reports on findings for TB 
control activities are provided for national use. 
In this longitudinal analysis, we imported the logarithm 
scale of TB incidence crude rates as dependent variable and 
year as independent variable to model. A crude incidence rate 
is the number of new TB cases in a specified population during 
a year (
𝑛𝑒𝑤 𝑐𝑎𝑠𝑒𝑠
𝑃𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛  
∗ 105 ). In situation that data arise from 
Poisson distribution, which is skewed log, transformation 
makes it approximate a normal distribution. Selection the 
maximum number of change-points in model depends on 
number of years (n), so, to identify change in trends, with 
regarding n= 15 years, segmented regression model with 
maximum 4 number of change-points was used10. Segmented 
linear regression is used for segmenting nonlinear regression 
models into linear segments and points between segments 
called change points11. 
The segmented regression has the following specification:  
E(y|x)=βi,0+βi,1x+δi,1(x-τi,1)
+ +…+δi,ki(x-τi,ki )
+  
Where 𝑘𝑖  is unknown number of change points for ith 
group (i=1,2), 𝜏𝑖 ,𝑙 (i=1,.., k) is the unknown change points, 𝛽𝑖,𝑙  
and  𝛿𝑖 are the regression parameters and (𝑥 − 𝜏𝑖 ,𝑗)
+ = (𝑥 −
𝜏𝑖 ,𝑗)  for(𝑥 − 𝜏𝑖 ,𝑗) > 0 . The details of segmented regression 
and APCs discussed previously.   
The Lerman’s grid search was used on 𝜏𝑖 ,𝑗, that uses last 
square estimation method, which carries out a grid search over 
trend to map minimum value of residuals sum of square 
function13. The APC, AAPC and its respective 95% 
confidence interval (95%CI) were used for description trend 
of TB. The heteroscedastic error was used to model the trends 
as the Poisson model. The comparability test was used to test 
whether two regression mean functions were parallel. The P-
value was estimated using permutation test of Monte Carlo. 
We used Bayesian Information Criterion (BIC) to choice 
final Model. Model with smallest BIC was considered as best 
model. Free source Join point 4.4.0 software available 
from http://srab.cancer.gov/joinpoint/ was used to perform this 
analysis.  
Due to retrospective nature of the study ethical approval 
was not required. 
Results 
Between 2001- 2015, a total of 154930 TB cases were 
registered by health surveillance systems in Iran. Of these, 
77155 (49.8%) were SP, 42327 (27.3%) were EPTB, 30521 
(19.7%) were SN and 4927 (3.1%) were relapse cases. For all 
types TB, the peak of incidence was related to 2001. Besides, 
the full range AAPC related to all forms of TB was -2.6 
(95%CI: -3.3, -1.9, P≤.0001) with two change-points in 2006 
and 2011. In addition, the trend of first (APC=-6.51, 95%CI: -
7.4, -5.4) and third (APC=-3.7, 95%CI:-5.4, -2.1) segments 
were downward, however, it was upward for second segment 
(APC=2.6, 95%CI: 1.3, 4). Figure 1a-d show the estimated 
trend of TB incidence rate for each form over 15 years. 
Accordingly, using the join point regression analysis, two 
change-points on incidence rate trend for all four TB forms 
were estimated. The pattern of trends for all TB forms were 
nearly same despite of different change times and rates. 
The AAPC results of SP, SN, EPTB and relapse incidence 
rates of TB for the 15 years, from 2006 to 2015 and from 2011 
to 2015 are shown in Table 1. 
Therefore, for all forms of TB, AAPCs of incidence rate 
trend for 15 years were significantly different from zero, the 
AAPCs from 2006 to 2015 and from 2011 to 2015 were 
significant at alpha=0.05. The highest reduction in incidence 
rate was estimated for SN TB at 3.6%, and the lowest reduction 
in incidence rate for SP TB at 2.1%. 
The estimated expected mean of segmented regression 
function for TB incidence rate were: 
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E(y|x)=80.65-0.039x+0.065 (x-2007)+ -0.066(x-2011)+            (Smear positive) 
E(y|x)=168.9-0.083x+0.095 (x-2006)+ -0.048(x-2011)+            (Smear Negative) 
E(y|x)=345.98-0.172x+0.198(x-2004) + -0.07(x-2012)+            (Extra-pulmonary) 
E(y|x)=204.74-0.102+0.13(x-2005) + -0.096(x-2011)+              (Relapse)  
 
(a) 
 
(b) 
(c) 
 
(d) 
Figure 1: Incidence rate trend of Smear-positive (a), Smear-Negative (b), Extra-pulmonary(c) and relapse rate (d) of TB in Iran during 2001-2015. The annual 
percent change (APC) is significantly different from zero at alpha=0.05  
Table 1: Average annual percent change (AAPC) results of tuberculosis in 
Iran during 2001-2015 
Period AAPC 95%  CI for AAPC Test sttistic P value  
Smear Positive     
2001-2015 -2.06 -3.05 -1.07 -4.05 0.001 
2006-2015  -1.05 -2.49 0.398 -1.42 0.153 
2011-2015  -3.95 -5.90 -1.90 -4.64 0.002 
Smear Negative     
2001-2015 -3.57 -5.02 -2.07 -5.08 0.001 
2006-2015  -1.01 -3.08 1.06 -1.03 0.300 
2011-2015  -3.64 -7.10 -0.071 -2.57 0.037 
Extrapulmonary     
2001-2015 -3.2 -4.85 -1.55 -3.75 0.001 
2006-2015  0.05 -1.82 1.96 0.05 0.954 
2011-2015  -3.09 -6.84 0.81 -1.55 0.119 
Relapse      
2001-2015 -3.36 -5.10 -1.58 -3.67 0.001 
2006-2015  -1.10 -3.18 1.01 -1.03 0.303 
2011-2015  -6.27 -10.43 -1.92 -3.37 0.012 
The segmented regression function demonstrates the 
expected SP incidence rate equal to 2.51 in 2050. Regarding 
the last segment without any change in trend, we can expect 
that the SP incidence rate to be 1.66 per 100000 in 𝑥  =2050.    
Hypothesis of parallelism trends between SP TB 
(P=0.460), SN TB (P=0.090) and EPTB trend (P=0.673) with 
relapse trend were accepted. The parallelism hypothesis of 
trends for all forms with refugee trend (P<0.001) as well as 
Gross Domestic Product (GPD) trend (P<0.0001) were 
rejected. 
Discussion 
This study was strikingly first national TB trend analysis 
after implementation DOTS strategy in Iran. The trend of TB 
in Iran has changed over the past 15 years. The estimated 
decreasing trend for first and third segments also increasing 
trend for second segment for all form TB incidence rate are 
generally in line with previous studies in Iran14. As a results of 
AAPC15years decreasing was slower than previous study in 
Iran,15,16 where both AAPC10year (1998-2008) and AAPC5year 
(2003-2008) were 4.5%. Moreover, it was slower than those of 
high-income countries were (annually 3.6% decries) 17. 
However, decreasing rate is steeper than both globally 
(AAPC10year=-1) and Eastern Mediterranean region 
(AAPC10years= -0.08) during 2001-201018. Considering last 
segment pattern for trend; hence, we expect about 52% 
reduction in TB incidence rate by 2030, compared with 2015. 
This demonstrates need for accelerating reduction rate to 
achieve the first milestones of the End TB Strategy (80% 
reduction) in Iran, attributable mainly to the second segment, 
and highlights the necessity to investigate the related factors. 
4 / 6 Epidemiologic Trend of Tuberculosis in Iran  
 
JRHS 2017; 17(2): e00380 
Subgroup analysis in different TB types could shed light on 
unknown aspects of the trend. 
The SP, SN, EPTB and relapse TB incidence rate declined 
significantly from 2001 to 2015, however, the trend of EPTB 
incidence rate was not significant from 2011 to 2015. The 
exact information underlying this pattern is unknown, but 
various factors such as poor access to primary health care 
centers, diagnostic delays, ethnicity, education, economic 
condition, immigration and pollution are involved in TB 
trend19. However, in this study the effects of immigration and 
GPD trend on national TB trend were not significant. In Iran, 
immigrants are allowed to settle only in some predetermined 
provinces, so it will be important to analyze parallelism of 
trend in province levels. As a report of ministry of Iran, from 
2005 to 2010 about 5000000 Afghani with illegal migration 
returned to Afghanistan. This population has an important role 
in TB trend, because of deportation fear; most of them do not 
refer to health care centers. Moreover the illegal migrations are 
not considered in reported immigration trend. In addition, 
economic level as well as health budget distributions are not 
equal among provinces in Iran20. These interactions may 
reduce the effects of immigration and economic factors on TB 
trend.    
The estimated changes point in TB trend were similar for 
all forms, therefore it can be due to health care systems 
activities in Iran. The inadequate number of laboratories for 
TB, in addition, delay in TB detection can cause fix trend for 
second segments. There were upward trend for TB detection 
(AAPC=2.5) and fix trend for successful treatment between 
2001-2008 in Iran.16 Moreover, delay in TB  detection is an 
important problem, and the mean of delay varied between 100 
and 216 days for different type of TB during 2006-2012 in 
Iran21. In addition, bias in EPTB and SN cases diagnosis is 
common when there is no adequate laboratory for 
confirmatory tests22. About 67.5% of patient with TB, in first 
time contact with private sectors 23, in addition, only 17% and 
7.5% of private sectors knew about TB diagnostic and 
treatment methods24. As a results of nonlinear trend for TB, it 
seems that effect of controlling programs were varied over 15 
years, hence for success of TB control it will be important to; 
1) Shorten inclusion of periodic courses for physicians in TB 
controlling programs, 2) Increase knowledge and sensibility of 
illegal immigrants related to TB and 3) Increase the number of 
local laboratory. 
Results of this model for SP trend is the same with 
spatiotemporal model6, where estimated national trend was 
declined at a rate of 3.7% for 10 years  (2001-2012) in Iran. 
Downward trend for last segment of SP TB may be due to 
improved health system strengthening following economical 
support from the Global Fund to Fight AIDS, tuberculosis and 
malaria for proposed TB control programs in 2008. After that, 
the local and regional laboratories for drug susceptibility 
testing are increased from 0.1 to 0.4 per 5 million population 
in 2011 as well as TB diagnostic service using culture from 2.6 
to 3.2 per 5 million population in 2010. In addition, MDR 
treatment centers were prepared, that have important effect on 
early detection rate. However, economic level was related with 
TB incidence rate trend18, but in this study, there was no 
parallelism trend between GDP and SP TB. It seems that 
improvement in economic level must be in direction that 
enhance facilities related to TB controlling programs. 
Regarding that there was no change in TB diagnostic methods 
and registration in this period, therefore, it is important to 
improve TB diagnostic and therapeutic facilities over time for 
reach the elimination of TB. In addition, regarding the 
previous studies in Iran it may result in treatment problem, 
where, during 2001-2008, case detection rate and success 
treatment rate were upward and fixed, respectively16. 
However, there is no uniform pattern for trend in provinces 
level, so we suggest estimating TB trend in provinces level for 
assessing health service programs.  
The SN TB incidence trend was relatively downward from 
2001 to 2006 and it was stable during 2006-2011, which is 
lower than the raising trend of 4.5% from 2001 to 2009 in 
Iran16. From 2005 to 2011, SN TB decreased with 30% annual 
rate in province level (Hamadan) of Iran25. It was downward 
in Saudis and non-Saudis during 2000 to 200926. The stable 
trend of SN TB may result in lower respiratory symptoms in 
these patients in comparison with SP TB patients, also 
diagnostic procedures of SN TB contrast SP TB are 
complicated, which may cause to different change point on 
trend result in delayed detection27. About half of SN cases will 
be transformed to SP TB without treatment28, hence, same 
pattern of trends between SN and SP is unavoidable. Hoverer, 
the trend of SN TB with SP TB was not parallel, which can 
result in different change-points on trends.     
About 27% (range: 20.5-29.2%) of TB cases were EPTB 
with stable trend of ratio during the study period. An EPTB 
rate with a range of 13- 48% was reported in Iran29. EPTB 
proportion of all TB cases increased from 48% to 53% from 
2000 to 2006 and 15.7% to 21% from 1993 to 2006 in England 
and US, respectively30,31. But this was higher than 22% 
reported for EMRO regions in 20142, possibly because of 
variation in population and diagnostic methods. Our study 
shows that the trend of EPTB incidence rate remained stable 
from 2011 to 2015 and from 2006 to 2015, but since the trend 
of pulmonary TB was downward, this has caused to an 
increase in the EPTB ratio among all TB cases in Iran. 
However, this increases was not significant. The EPTB is often 
perceived more as a clinical property than a public health 
problem, as unpublished results of our work shows that case 
detection rate was stable during 2006-2011 and then decreased 
significantly since 2011 in Iran, so the upward trend of second 
segment and stable trend of EPTB for third segment maybe 
related to increasing incidence of EPTB cases in Iran, and 
probably is not a result of over-diagnosis. 
We observed decreasing trend in relapse rate between 2001 
and 2015, although fluctuations were seen. In this study 
relapse incidence rate varied between 0.051 – 0.07 per 100000 
population, that it is higher than the reported relapse incidence 
rate in Golstan (0.034 per 100000), as a high TB burden 
provinces in Iran, in 20097. The average relapse rate was 
estimated as 9.62% from 2006 to 2010 in Korea32.  
Accordingly, it was higher than the 0.04 probability of 
recurrent TB in ideal conditions 33 and 4.3% relapse proportion 
in Taiwan during 2004-2008, this ratio can lade to same pattern 
change of relapse and TB incidence. The slope of decreasing 
for last segment was slightly steeper than other TB forms. 
During the period from 2011 to 2014, three MDR TB inpatient 
centers and eight regional laboratories began to provide TB 
control services in Iran. Additionally, national online TB guide 
examination was conducted from 20124. Considering second 
change-points, these improvements have important role in 
decreasing TB incidence rate. SP, SN and EPTB are associated 
with a higher risk of relapse34. Therefore, efforts to control and 
management all other type TB can be important to decreasing 
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relapse cases. Classification of patients for treatment of TB 
into high risk and low risk groups can be effective in reduction 
of relapse cases34. 
There are several limitations to our study, first, incomplete 
data from individual as well as variables on demographic and 
behavioral factors, and socio-economic factors were not 
collected. However, in new registry systems this factors is 
included, this make difficult explanation of trends. Second, 
studies of TB trend in country level is too low, so this makes 
it difficult to compare the results. The segmented regression is 
inadequate to regress data including outliers, so it is necessary 
to extension this model to overcome the outlier problems. 
Conclusions 
All TB forms have decreased from 2001 to 2015 with 
different rate, while it remains as a health problem in Iran and 
is important to accelerating the reduction rate. The increase in 
the EPTB rates with respect to the other forms of TB cases is 
a point of concern highlighting the importance of 
strengthening the services towards this cases . There are 
association among expanding laboratories and private TB 
treatment hospitals with change-points on TB trend. Although 
association among TB trend with immigration and GDP were 
insignificant, attention must be paid to illegal immigration and 
financial support toward TB controlling programs. For success 
TB control, specifically relapse cases because of high 
variability, will be important to inclusion continues programs  
along with short- interval monitoring based on provinces and 
high risk groups. This study would help better understanding 
of the trend pattern of TB and provide important information 
for the improve stop TB strategies. Cluster provinces based on 
TB trend risks for assign resources according to severity of TB 
controlling problems is recommended. 
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Highlights  
 Reduction on TB incidence rate have decreased from 
4.5% to 3.3% per year.  
 Upward and fix trend of Extra pulmonary incidence 
rate trend is a point of concern. 
 There were association among expanding the number 
laboratories and private TB treatment hospitals with 
change-points on TB trend. 
 There were non-parallelism trend among TB incidence 
rate and immigration as well as GPD 
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